Image from Google Jackets

Acute myelogenous leukemia a case report / Ma. Flora Y. Redor.

Contributor(s): Language: english Publication details: Fairview, Quezon City: Department of Child Heath, FEU-NRMF, 2008.Description: 21 pages: tables; (in folder)Content type:
  • text
Media type:
  • unmediated
Carrier type:
  • volume
LOC classification:
  • CH 2008 0001
Summary: Abstract: A Case of a 15 year old, female with history of fever, constipation, black tarry stools, anemia malaise, easy fatigability and headache is presented. Acute myelogenous leukemia (AML) French American British (FAB) M3 classification was confirmed by bone marrow biopsy. The myelogenous leukemia are heterogenous group of disease characterized by infiltration of the blood, bone marrow and other tissues by neoplastic cells of the hematopoietic system. AML accounts for 11% of the cases of childhood leukemia in the USA, with approximately 370 children diagnosed with AML annually. In the Philippines, it ranks 5th among the killer diseases. Despite all ongoing efforts to improve treatment and supportive care, childhood AML still remains a challenging disease. The current 5-year survival rate approaches 50% with the use of intensive-timing chemotherapy (CCG 2891).
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Status Date due Barcode
Room Use Far Eastern University - Nicanor Reyes Medical Foundation Research CH 2008 0001 (Browse shelf(Opens below)) Available R000033

Includes appendices and bibliographical references.

Abstract: A Case of a 15 year old, female with history of fever, constipation, black tarry stools, anemia malaise, easy fatigability and headache is presented. Acute myelogenous leukemia (AML) French American British (FAB) M3 classification was confirmed by bone marrow biopsy. The myelogenous leukemia are heterogenous group of disease characterized by infiltration of the blood, bone marrow and other tissues by neoplastic cells of the hematopoietic system. AML accounts for 11% of the cases of childhood leukemia in the USA, with approximately 370 children diagnosed with AML annually. In the Philippines, it ranks 5th among the killer diseases. Despite all ongoing efforts to improve treatment and supportive care, childhood AML still remains a challenging disease. The current 5-year survival rate approaches 50% with the use of intensive-timing chemotherapy (CCG 2891).

Research - Department of Child Health

There are no comments on this title.

to post a comment.